Exactech Cleared By FDA For U.S. Distribution Of Equinoxe(R

Exactech, Inc. Cleared By FDA For U.S. Distribution Of Equinoxe(R) Reverse Shoulder
Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products including orthopaedic implants and biologic materials, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Equinoxe(R) Reverse Shoulder, the latest component in the company's shoulder arthroplasty line.